Skip to content

AstraZeneca Pharmaceuticals LP v. Kennedy

Pending petition

Docket No. Op. BelowArgument Opinion Vote Author Term
25-348 3d Cir. TBD TBD TBD TBD TBD

Issue: Whether the Inflation Reduction Act of 2022 implicates an interest of pharmaceutical manufacturers that is protected by the Due Process Clause.

DateProceedings and Orders (key to color coding)
07/24/2025Application (25A115) to extend the time to file a petition for a writ of certiorari from August 6, 2025 to September 20, 2025, submitted to Justice Alito.
07/28/2025Application (25A115) granted by Justice Alito extending the time to file until September 20, 2025.
09/19/2025Petition for a writ of certiorari filed. (Response due October 24, 2025)
09/26/2025Motion to extend the time to file a response from October 24, 2025 to November 24, 2025, submitted to The Clerk.
09/29/2025Motion to extend the time to file a response is granted and the time is extended to and including November 24, 2025.
11/20/2025Motion to extend the time to file a response from November 24, 2025 to December 24, 2025, submitted to The Clerk.
11/21/2025Motion to extend the time to file a response is granted and the time is further extended to and including December 24, 2025.
12/18/2025Motion to extend the time to file a response from December 24, 2025 to January 2, 2026, submitted to The Clerk.
12/19/2025Motion to extend the time to file a response is granted and the time is further extended to and including January 2, 2026.
01/02/2026Brief of respondents Secretary of Health and Human Services, Robert F. Kennedy, et al. in opposition filed.
01/02/2026Waiver of the 14-day waiting period for the distribution of the petition pursuant to Rule 15.5 filed by petitioner.